Keyphrases
Human Immunodeficiency Virus Type 1 (HIV-1)
26%
Ethiopia
24%
HIV Transmission
16%
HIV Status
11%
AIDS/HIV
10%
Vitamin A
9%
Tuberculosis
9%
Infant HIV
8%
Vitamin A Supplementation
8%
Breast Milk
8%
Health Facilities
8%
HIV-negative
8%
Haiti
8%
HIV Patients
7%
Zimbabwe
7%
Haitian
7%
HIV-positive
7%
Zimbabwean
7%
Adolescents Living with HIV
7%
Nevirapine
7%
High Dose
7%
HIV-positive Women
7%
Addis Ababa
7%
Human Immunodeficiency Virus Infection
7%
Khat Use
7%
Antiretroviral Therapy
6%
HIV Infection
5%
Isoniazid Preventive Therapy
5%
Breast
5%
Risk of Death
5%
Highly Active Antiretroviral Therapy (HAART)
5%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
5%
Filariasis
5%
Antenatal Care
5%
Viral Load
5%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus Infection
15%
Adolescent
10%
Anemia
10%
Nevirapine
10%
Highly Active Antiretroviral Therapy
9%
Infection
9%
Human Milk
9%
Prophylaxis
9%
Pediatrics
8%
Antiretroviral Therapy
8%
Retinol
7%
Childbirth
7%
Virus Transmission
7%
Supplementation
7%
Human Immunodeficiency Virus 1
7%
Cohort Analysis
6%
Isoniazid
5%
Prenatal Care
5%
Infancy
5%
Nursing and Health Professions
Human Immunodeficiency Virus
80%
Human Immunodeficiency Virus Infection
15%
Retinol
7%
Virus Typing
7%
Nevirapine
7%
Supplementation
7%
Prophylaxis
7%
Prevalence
6%
Prenatal Care
6%
Predictive Value
6%
Infection
5%
World Health Organization
5%
Single Drug Dose
5%